The world’s first … Britain issues emergency approval for a vaccine (Biontec and Pfizer)



[ad_1]

The German company “Biontech” and “Pfizer” US pharmaceuticals announced on Wednesday that the British Medicines Regulatory Authority has issued an emergency approval for the anti-Corona vaccine developed by the two companies.

The United Kingdom has become the first country in the world to grant a license to the US vaccine company Pfizer and the German laboratory Biontech against Covid-19, which will be available from next week.

“The government approved on Wednesday the recommendation of the Independent Agency for the Regulation of Medicines and Health Products to authorize the use of the Pfizer / Bionic Coronavirus vaccine,” said the spokesman for the Ministry of Health.

He noted that “the vaccine will be available everywhere in the UK from next week, and Health Minister Matt Hancock welcomed this step and said:” The UK is the first country in the world to have a vaccine. clinically approved.

The spokesman for the Ministry of Health explained that the green light was given “after months of careful clinical trials and in-depth data analysis by experts from the Medicines and Health Products Regulatory Agency, who concluded that the vaccine meets their strict standards. of safety, quality and efficacy “.

For his part, Albert Burla, head of Pfizer Laboratories, welcomed in a statement the authorization to use the vaccine in the United Kingdom, calling it a “historic moment”.

Priority will be given to vaccinating inmates of nursing homes, health workers, the elderly and the most vulnerable.

The world’s first approval

This approval gives the British the green light to receive the vaccine before the European Union and the United States of America, and is also the first approval of the vaccine in the world.

The two companies announced today, Wednesday, that they expect the first shipments to reach the UK within a few days, and said in a statement, “that the first emergency approval of the Covid-19 vaccine is a pioneering scientific quantum leap.”

Vaccine effectiveness

For the Biontech / Pfizer vaccine, an extensive series of tests has shown an efficacy that provides 95% protection against the Corona virus.

The two companies said after the conclusion of recent analyzes that the vaccine worked equally well in all age groups and other demographic differences and showed virtually no serious side effects.

The protection rate provided by vaccination for people over 65 years of age is more than 94%.

These positive results are related to the prevention of Covid-19 disease, and it is not yet clear to what extent the vaccine also protects against infection and the possibility of virus transmission.

The European Medicines Agency, “IMA”, also intends to make a decision on the recommendation for approval of the Corona vaccine for Biontec and Pfizer this December.

The agency announced Tuesday that the results of the review will be available no later than December 29.



[ad_2]